Financials
- Market Capitalization 39.21 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.68
ratio cours/chiffre d'affaires
5 743.48
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 239 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 664.45 USD | +1.27% | +0.55% | +8.01% | +21.77% | 69.66 B USD | ||
| 299 | ARGX argenx SE - American Depositary Shares | 862.93 USD | +0.41% | -5.19% | -3.10% | +50.86% | 53.40 B USD | ||
| 389 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 279.14 USD | -0.75% | -26.25% | -0.77% | -13.09% | 37.27 B USD | ||
| 487 | MRNA Moderna, Inc. - Common Stock | 68.28 USD | +1.25% | -7.48% | +21.47% | +112.12% | 27.09 B USD |